None of these

Latest Innovations

In vivo Thickness Mapping of the Tympanic Membrane

 

 

Dr. Stephen Boppart from has developed a new method of mapping the thickness of the tympanic membrane. This method uses LCI and video otoscopy data to...

 

 

Dr. Stephen Boppart from has developed a new method of mapping the thickness of the tympanic membrane. This method uses LCI and video otoscopy data to piece together a full image of the tympanic membrane and overlay that image with thickness measurements. This will allow physicians to noninvasively examine tympanic membrane thickness leading to more accurate and less invasive diagnose middle ear infections.

Point of Care Ocular Globe Injury Diagnostic Device

Dr. Pan from the University of Illinois at Urbana-Champaign has developed a point of care device that can detect a penetrating ocular globe injury. Unlike current point of...

Dr. Pan from the University of Illinois at Urbana-Champaign has developed a point of care device that can detect a penetrating ocular globe injury. Unlike current point of care diagnostic tests for ocular globe injuries, which require a trained physician to subjectively identify a change in the color of a dye placed onto the ocular surface, the invention can be administered by a nurse or technician. This technology will allow for faster, cheaper, and more mobile means of diagnosing certain eye injuries.

CRISPR-AID

Dr. Zhao from the University of Illinois at Urbana-Champaign has developed a novel method for combinatorial genome...

Dr. Zhao from the University of Illinois at Urbana-Champaign has developed a novel method for combinatorial genome editing in yeast. With the use of CRISPR-AID technology targeted genes can be simultaneously upregulated, downregulated, and deleted allowing discovery of synergistic effects to enhance strain phenotypes. Utilizing this technology will allow fast generation of novel strains suited to industrial applications. In addition Dr. Zhao has generated novel CRISPR constructs optimized for CRISPRa and CRISPRi applications for use in yeast. This is the first use of orthogonal CRISPR strains in yeast and will greatly expand the toolbox for yeast genome engineering.